Exosite Occupation by Heparin Enhances the Reactivity of Blood Coagulation Factor IXa

Biochemistry

Volumn 43, Issue 10, 2004, Pages 2978-2986

  Neuenschwander, Pierre F ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CHEMICAL ACTIVATION; COAGULATION; FLUORESCENCE; PHYSIOLOGY;

BLOOD COAGULATION FACTOR;

BIOCHEMISTRY;

APROTININ; BLOOD CLOTTING FACTOR 9A; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE SULFATE;

ARTICLE; COMPETITIVE INHIBITION; DRUG BINDING SITE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBSTRATE; EXOSITE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REACTION ANALYSIS; SURFACE PLASMON RESONANCE;

ANIMALS; APROTININ; BLOOD COAGULATION TESTS; CATTLE; CHROMOGENIC COMPOUNDS; DRUG SYNERGISM; ENZYME ACTIVATION; FACTOR IXA; HEPARIN; HYDROLYSIS; KINETICS; OLIGOPEPTIDES; PROTEIN BINDING; SURFACE PLASMON RESONANCE; SWINE;

BOVINAE;

EID: 1542357650     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi035452d     Document Type: Article

References (45)

1. Roberts, H. R., and Tabares, A. H. (1995) in Molecular Basis of Thrombosis and Hemostasis (High, K. A., and Roberts, H. R., Eds.) pp 35-50, Marcel Dekker, Inc., New York.
2. Jesty, J., and Nemerson, Y. (1995) in Williams Hematology (Beutler, E., Lichtman, M. A., Collar, B. S., and Kipps, T. J., Eds.) pp 1227-1238, McGraw-Hill, Inc., New York.
3. Colman, R. W., Marder, V. J., Salzman, E. W., and Hirsh, J. (1994) in Hemostasis and Thrombosis. Basic Principles and Clincal Practice (Colman, R. W., Hirsh, J., Marder, V. J., and Salzman, E. W., Eds.) pp 3-18, J.B. Lippincott Co., Philadelphia.
4. van Dieijen, G., Tans, G., Rosing, J., and Hemker, H. C. (1981) The role of phospholipid and factor VIIIa in the activation of bovine factor X, J. Biol. Chem. 256, 3433-3442.
5. 2+ and phospholipids to the activation of human blood-coagulation factor X by activated factor IX, Biochem. J. 223, 607-615.
6. Mertens, K., van Wijngaarden, A., and Bertina, R. M. (1985) The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX, Thromb. Haemost. 54, 654-660.
7. van Dieijen, G., van Rijn, J. L. M. L., Govers-Riemslag, J. W. P., Hemker, H. C., and Rosing, J. (1985) Assembly of the intrinsic factor X activating complex-Interactions between factor IXa, factor VIIIa and phospholipid, Thromb. Haemost. 53, 396-400.
8. Suomela, H., Blomback, M., and Blomback, B. (1977) The activation of factor X evaluated with synthetic substrates, Thromb. Res. 1, 267-281.
9. Byrne, R., Link, R. P., and Castellino, F. J. (1980) A kinetic evaluation of activated bovine blood coagulation factor IX toward synthetic substrates, J. Biol. Chem. 255, 5336-5341.
10. McRae, B. J., Kurachi, K., Heimark, R. L., Fujikawa, K., Davie, E. W., and Powers, J. C. (1981) Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates, Biochemistry 20, 7196-7206.
11. Lottenberg, R., Christensen, U., Jackson, C. M., and Coleman, P. L. (1981) in Methods in Enzymology (Lorand, L., Ed.) pp 341-361, Academic Press, New York.
12. Link, R. P., and Castellino, F. J. (1983) Kinetic properties of bovine factor IXa alpha and IXa beta toward synthetic substrates, Biochemistry 22, 999-1005.
13. Castillo, M. J., Kurachi, K., Nishino, N., Ohkubo, I., and Powers, J. C. (1983) Reactivity of bovine blood coagulation factor IXa-beta, factor Xa-beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X, Biochemistry 22, 1021-1029.
14. Neuenschwander, P. F., McCollough, J., McCallum, C. D., and Johnson, A. E. (1997) A Conformational Change in the Active Site of Blood Coagulation Factor IXa is Associated with an Increase in Activity Upon Treatment with Ethylene Glycol, Thromb. Haemost. Suppl., 428.
15. Stuerzebecher, J., Kopetzki, E., Bode, W., and Hopfner, K. P. (1997) Dramatic enhancement of the catalytic activity of coagulation factor IXa by alcohols, FEBS Lett. 412, 295-300.
16. Yang, L. K., Manithody, C., and Rezaie, A. R. (2002) Localization of the heparin binding exosite of factor IXa, J. Biol. Chem. 277, 50756-50760.
17. Sheehan, J. P., and Phan, T. M. (2001) Phosphorothioate oligo-nucleotides inhibit the intrinsic tenase complex by an allosteric mechanism, Biochemistry 40, 4980-9490.
18. Rosenberg, J. S., McKenna, P. W., and Rosenberg, R. D. (1975) Inhibition of human factor IXa by human antithrombin, J. Biol. Chem. 250, 8883-8888.
19. Kurachi, K., Fujikawa, K., Schmer, G., and Davie, E. W. (1976) Inhibition of bovine factor IXa and factor Xa (beta) by antithrombin III, Biochemistry 15, 373-377.
20. DiScipio, R. G., Kurachi, K., and Davie, E. W. (1978) Activation of human factor IX (Christmas factor), J. Clin. Invest. 60, 1528-1538.
21. Villaneuva, G. B., and Danishefsky, I. (1977) Evidence for a heparin-induced conformational change on antithrombin III, Biochem. Biophys. Res. Commun. 74, 803-809.
22. Villaneuva, G. B. (1984) Predictions of the secondary structure of antithrombin III and location of the heparin binding site, J. Biol. Chem. 259, 2531.
23. Olson, S. T., and Bjoerk, I. (1992) Role of protein conformational changes, surface approximation and protein cofactors in heparin-accelerated antithrombin-proteinase reactions, Adv. Exp. Med. Biol. 313, 155-165.
24. Olson, S. T., Bjoerk, I., Sheffer, R., Craig, P. A., Shore, J. D., and Choay, J. (1992) Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement, J. Biol. Chem. 267, 12528-12538.
25. Griffith, M. J. (1982) Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin, J. Biol. Chem. 257, 7360-7365.
26. Yang, L., Manithody, C., and Rezaie, A. R. (2002) Localization of the Heparin Binding Exosite of Factor IXa, J. Biol. Chem. 277, 50756-50760.
27. Chang, J. L., Jin, J. P., Lollar, P., Bode, W., Brandstetter, H., Hamaguchi, N., Straight, D. L., and Stafford, D. W. (1998) Changing residue 338 in human factor IX from arginine to Alanine causes an increase in catalytic activity, J. Biol. Chem. 273, 12089-12094.
28. Schmaier, A. H., Dahl, L. D., Hasan, A. A. K., Cines, D. B., Bauer, K. A., and Van, N. W. E. (1995) Factor IXa inhibition by protease nexin-2/amyloid Beta-protein precursor on phospholipid vesicles and cell membranes, Biochemistry 34, 1171-1178.
29. Schmaier, A. H., Dahl, L. D., Rozemuller, A. J. M., Roos, R. A. C., Wagner, S. L., Chung, R., and Van, N. W. E. (1993) Protease nexin-2/amyloid Beta protein precursor. A tight-binding inhibitor of coagulation Factor IXa, J. Clin. Invest. 92, 2540-2545.
30. Hsu, Y. C., Hamaguchi, N., Chang, Y. J., and Lin, S. W. (2001) The distinct roles that Gln-192 and Glu-217 of factor IX play in selectivity for macromolecular substrates and inhibitors, Biochemistry 40, 11261-11269.
31. Rezaie, A. R., and Esmon, C. T. (1993) Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors, J. Biol. Chem. 268, 19943-19948.
32. Neuenschwander, P. F., and Morrissey, J. H. (1995) Alteration of the substrate and inhibitor specificities of blood coagulation factor VIIa: Importance of amino acid residue K192, Biochemistry 34, 8701-8707.
33. Rezaie, A. R., and Esmon, C. T. (1995) Contribution of residue 192 in factor Xa to enzyme specificity and function, J. Biol. Chem. 270, 16176-16181.
34. Rezaie, A. R., and Esmon, C. T. (1996) Molecular basis of residue 192 participation in determination of coagulation protease specificity, Eur. J. Biochem. 242, 477-484.
35. Segel, I. H. (1975) Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, John Wiley & Sons, New York.
36. O'Shannessy, D. J., Dobersen, M. J., and Quarles, R. H. (1984) A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties, Immunol. Lett. 8, 273-277.
37. Badellino, K. O., and Walsh, P. N. (2001) Localization of a heparin binding site in the catalytic domain of factor XIa, Biochemistry 40, 7569-7580.
38. Delaria, K. A., et al. (1997) Characterization of placental bikunin, a novel human serine protease inhibitor, J. Biol. Chem. 272, 12209-12214.
39. Olson, S. T., and Chuang, Y. J. (2002) Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases, Trends Cardiovasc. Med. 12, 331-338.
40. Rezaie, A. R., He, X., and Esmon, C. T. (1998) Thrombomodulin Increases the Rate of Thrombin Inhibition by BPTI, Biochemistry 37, 693-699.
41. Guinto, E. R., Ye, J., Le, B. B. F., and Esmon, C. T. (1994) Glu192→Gln substitution in thrombin yields an enzyme that is effectively inhibited by bovine pancreatic trypsin inhibitor and tissue factor pathway inhibitor, J. Biol. Chem. 269, 18395-18400.
42. Jordan, R. E., Oosta, G. M., Gardner, W. T., and Rosenberg, R. D. (1980) The binding of low molecular weight heparin to hemostatic enzymes, J. Biol. Chem. 255, 10073-10080.
43. Sichler, K., Banner, D. W., D'Arcy, A., Hopfner, K. P., Huber, R., Bode, W., Kresse, G. B., Kopetzki, E., and Brandstetter, H. (2002) Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions, J. Mol. Biol. 322, 591-603.
44. Bedsted, T., Swanson, R., Chuang, Y. J., Bock, P. E., Bjork, I., and Olson, S. T. (2003) Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites, Biochemistry 42, 8143-8152.
45. Barrow, R. T., Parker, E. T., Krishnaswamy, S., and Lollar, P. (1994) Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator, J. Biol. Chem. 269, 26796-26800.